tirzepatide no bmi required New drug delivers significant and long-lasting weight loss Tirzepatide leads to weight reduction

This extended half-life is one reason tirzepatide is taken once weekly, the medication remains active between doses

Final Thoughts The GLOW protocol works because it respects how biology actually heals

Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB (2015) Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition

Step 2: Assess risk features Determine whether the patient is in dose escalation, has active GI symptoms, uses a high dose, has known gastroparesis, has long-standing diabetes with autonomic neuropathy, has severe GERD or hiatal hernia, or is undergoing general anesthesia/deep sedation